Paradigm Biopharma logo

Paradigm Biopharma jobs and careers

Melbourne, Victoria, Australia

About Paradigm Biopharma

Paradigm Biopharma (PAR) listed on the ASX in August 2015. Paradigm Biopharma's focus is on repurposing pentosan polysulphate sodium (PPS) for the treatment of diseases sustained by inflammation, where a key feature of the activity of PPS is its anti-inflammatory and tissue regenerative properties.

Founded
2014
Employees
11 to 50
Headquarters
Melbourne

Leadership

The top of Paradigm Biopharma's org chart, with how many people report into each leader.

PRPhoto of Paul Rennie

Paul Rennie

Founder & Chairman

9 reports

DSPhoto of Donna Skerrett

Donna Skerrett

Chief Medical Officer

7 reports

SWPhoto of Simon White

Simon White

Director of Investor Relations

Board

JG

John Gaffney

Non-Executive Director

AM

Amos Meltzer

Non-Executive Director

KH

Kevin Hollingsworth

Company Secretary